About MATTER

MATTER is a community of healthcare innovators, an incubator of ideas, and a catalyst for change. We are boots-on-the-ground entrepreneurs pushing against the status quo and established institutions dedicated to improving patients’ lives. At MATTER we are hungry for change, and we’re working together to solve real and complex healthcare problems.

What We Do

One thing’s for certain: complex healthcare challenges aren’t solved in silos, so what we do at MATTER is equip, embolden, and empower players from across the healthcare ecosystem to tackle them together.


We equip.
  • A curriculum purpose-built for healthcare innovators
  • Mentors-in-residence who’ve built healthcare businesses and have deep expertise in healthcare, technology, and entrepreneurship
  • State-of-the-art facilities including the Shop, the Stage, and the AMA Interaction Studio
We embolden.
  • A culture of innovation, experimentation, and collaboration so crucial in today’s changing healthcare landscape
  • Inspirational keynotes, fireside chats, and panels
  • A community of like-minded individuals who are passionate about solving healthcare challenges
We empower.
  • Access to innovators from across the healthcare ecosystem including pharmaceutical, medical device, diagnostics, and health IT companies; venture capitalists; health systems and hospitals; payers; scientists; and physicians
  • Innovative programs, built with our partners, designed to enhance collaboration between stakeholders

Our mission is to accelerate the development of technologies that solve the right healthcare problems in the right ways. We’re here to do something that matters. Join us.

Our Space

Hundreds of healthcare and life sciences entrepreneurs, innovators, and industry leaders participated in the design of our facility. Our 25,000-square-foot space includes workspace, meeting and learning space, and specialty healthcare environments.

JOIN US

AMA Interaction Studio

The AMA Interaction Studio replicates an outpatient environment in which entrepreneurs and physicians collaborate. Learn more.

The Shop

The Shop is our medical device prototyping lab for entrepreneurs and tinkerers to build, iterate, and test.

The Simulation Stage

The Simulation Stage is our high-acuity simulation environment, built in partnership with the Jump Training Education and Simulation Center at OSF Healthcare. Learn more.

Learn More

Join us for an event at MATTER. Or to arrange a tour, drop us a line.

Team

We’re a team of restless innovators working to change healthcare. We believe rapid technology advances hold the keys to better health and healthcare. We're ambitious, entrepreneurial, and optimistic. We're here to change lives. If that sounds like you, check out our open positions.


Steven Collens

CEO Steven Collens is CEO of MATTER, the healthcare technology incubator and innovation center. MATTER opened in February 2015 and nurtures entrepreneurs and innovators building next-generation health IT, medical device, diagnostic and biopharma technologies. MATTER works with 200 healthcare technology ventures and the company partners with 10 hospitals and health systems, five universities and more than 50 industry-leading companies. Steven is also senior advisor at Pritzker Group Venture Capital.

Prior to assuming his current role, Steven was senior vice president at Pritzker Group, the investment firm led by Tony and J.B. Pritzker. In that capacity, he led the team that created 1871, Chicago’s center for digital startups that now houses more than 400 early-stage companies. He previously worked at Abbott in a variety of domestic and international functions, including product management, policy and public affairs. In 2005, Steven helped found ConstantWellness.com to give patients control over their health data and allow healthcare providers to coordinate care of their patients. Prior to Abbott, Steven served as legislative assistant to U.S. Senator Carol Moseley-Braun.

Steven holds an MBA from Northwestern University’s Kellogg School of Management and a BA from Washington University in St. Louis. He serves on the boards of 1871, the Ann & Robert H. Lurie Children’s Hospital of Chicago, the Chicago High School for the Arts and Hubbard Street Dance Chicago. He is also a Leadership Greater Chicago fellow and a member of the Economic Club of Chicago and the Commercial Club of Chicago.

Josh Chapman

COO With more than 20 years of leadership experience, Josh Chapman joined MATTER as COO in March 2017. In his role, Josh is responsible for all non-sales activities at MATTER including marketing, operations, and programs.

Prior to MATTER, Josh was the CEO of GiveForward, the first personal crowdfunding site in the United States that was acquired by YouCaring in 2017. Before that role, Josh was a member of the senior management team at Cars.com through their $1.8 billion acquisition by Gannett. Josh has also spent time at Allianz Global Assistance and Conduent (Xerox) where, as a division vice president, he launched a 50 person project and built it into a $65 million business with over 2,200 employees.

A proud VCU alumni, Josh is also a published author and keynote speaker. In 2013 he was recognized as the Best Customer Service Leader by the International Customer Management Institute (ICMI). He also serves on multiple boards and as an advisor to startups.

Melissa Lederer

Strategic Initiatives Melissa Lederer is a strategic marketing consultant who leads MATTER’s marketing and communications functions. A seasoned professional with nearly 20 years of broad experience in both agency and corporate settings, Melissa has served a variety of digital and traditional businesses of all sizes and has a passion for working with high-growth startups to help build their brand foundations. Most recently, Melissa was part of the launch team for 1871, Chicago’s digital hub for entrepreneurs, and served as its chief marketing officer for more than 2 years. Prior to starting her marketing consultancy in 2008, Melissa was the SVP of marketing for Q Interactive (formerly CoolSavings) where she oversaw all marketing, communications and creative functions and served on the company’s senior leadership team. Melissa is a graduate of the University of Wisconsin-Madison and currently resides with her family in Glencoe, IL.

Arun Bhatia

Program Director Arun has a deep passion for the design and strategic growth of new healthcare and life-science ventures. He has held multi-faceted roles related to early-stage venture development including innovation strategy design and leading the intra-preneurship program at Baxter Healthcare, corporate venture evaluation and investing through Baxter Ventures, and university-stage start-up development and investment at IllinoisVENTURES. Arun’s passion for healthcare innovation was fostered through an MBA in entrepreneurship from the University of Chicago Booth School of Business as well as an MS in biotechnology from the Illinois Institute of Technology.

Dionne Braddix

Marketing Director With over 15 years of experience in marketing and brand strategy, Dionne is excited to bring her diverse experience to the MATTER team. Most recently, Dionne served in a senior management role with Abbott Laboratories, focused on brand strategy and brand experience for its global diagnostics division. Her previous experience includes work with 3M and the Cleveland Clinic. Dionne began her healthcare career on Capitol Hill, first in the US Senate and then as a federal lobbyist, specializing in appropriations and strategic partnerships in the healthcare, education, environment, and arts industries. Passionate to create social change through marketing, Dionne holds an MBA with concentrations in marketing and health systems management, and certificate in nonprofit management, from Case Western Reserve University.

Vincent Cabansag

Operations Director Vincent is an entrepreneur and developer who makes organizations effective and leads others to do the same. He brings a decade of start-up experience to MATTER. For the last 4 years, Vincent led operations at the The Starter League, the school that pioneered the bootcamp revolution in 2011. Before that, he managed and helped scale Chicago Apartment Finders, which was acquired by Coldwell Banker. Over the years, Vincent has earned a reputation as a respected and multi-talented leader with extensive experience in education, compliance, business development, project management, IT, sales, and marketing. He is also a developer, designer, and photographer.

Kelli Enright

Partnerships Director Kelli Enright is the partnerships director at MATTER. In this role she is responsible for building relationships with key stakeholders across the healthcare industry. Kelli collaborates closely with the CEO and VP of programs to develop mutually beneficial partnerships that encourage collaboration between industry partners and MATTER members. Kelli is passionate about bringing industry experts, leaders, and entrepreneurs together to innovate, ideate, and disrupt the healthcare status quo. Kelli has over 10 years of management consulting experience in a wide range of strategy and operations projects across various industries for Slalom Consulting and Booz Allen Hamilton. Prior to consulting she was a strategic pricing analyst for Northrop Grumman. Kelli has her BA from University of Puget Sound and is originally from Washington state.

Soma Ghoshal-Diaz

Program Director Soma Ghoshal-Diaz is a program director at MATTER. In this role, she is responsible for initiating and managing innovation challenges for key stakeholders. She is passionate about encouraging innovators and entrepreneurs to improve the healthcare industry through creation and ideation. Soma has 10 years of project management experience in international development and global health, most recently working for the strategic consulting firm, Vital Wave. Prior to consulting, Soma was a project manager at NetHope, a nonprofit dedicated to effective technological solutions in developing countries. Soma has her BA from New York University and completed her MPH at The George Washington University.

Mark Kaiser

Business Development Director As director of business development, Mark’s mission is to establish long-term relationships with MATTER partners to enhance the innovation capabilities of healthcare organizations that align with MATTER’s value proposition. As a member of the leadership team, he tracks and reports on developing healthcare trends and strategic opportunities to expand and deepen partner relationships. Prior to joining MATTER, Mark represented orthopedic and neurosurgical device companies Arthrex and Globus Medical, respectively, as well as Dupuy Synthes Spine, a subsidiary of J&J. There, he worked primarily to restore growth in sales territories with declining numbers. Mark graduated from the University of Missouri and explored concepts in entrepreneurship through graduate courses there.

Jessica Puri

Executive Assistant Jessica is a public health professional with years of experience in scientific writing, health research, and public health communication on the bachelor’s and master’s level. At MATTER, she serves as executive assistant to the CEO and COO. In this role, she is the liaison between executives and their internal and external partners – facilitating the flow of communication and providing administrative assistance.

Kelli Rojek

Associate Manager, Membership Experience Kelli brings customer service and strategy expertise to MATTER’s member experience team. She has worked in both nonprofit and startup settings, most recently as the coaching director at GiveForward, a startup focused on helping communities support loved ones experiencing personal hardship by coordinating meal delivery, fundraising, and social networking. Kelli crafted strategy to maximize fundraising success, customer development, and front line support for users, and served as a liaison between department and external partners. In this position, she helped users raise millions of dollars while maintaining a high standard of customer support. Kelli has her undergraduate degree from Western Michigan University, and her master's in leadership and professional administration from Duquense University.

Paige Edmiston

Marketing Associate As marketing associate, Paige helps MATTER strategically tell its stories by supporting communications, content creation, social media, and other marketing initiatives. Prior to joining MATTER, she helped Geocaching – the company behind the world’s largest treasure hunt game – develop its brand voice and story, as well as increase customer conversion and retention. Paige also founded nonprofit The Sidekick Collective, which provides extraordinary teenagers with seed funding for ideas to make their schools and communities better. She studied international development and global health at the University of Washington in Seattle.

Seide Hood

Events Associate Seide works with MATTER members, partners, and the community to curate and execute events that highlight healthcare’s latest discoveries and technologies. Seide believes that innovation is most impactful when realized through a diverse network, and is passionate about building creative collaborations to inspire social change. With a background in public policy and economic development, Seide is an advocate for building sustainable business opportunities for healthcare entrepreneurs. She hails from the great state of Minnesota by way of San Francisco and is a graduate of the University of Minnesota.

Samuel Lee

Program Associate Samuel assists in the development of MATTER programs, events, and mentor offerings to provide our members and partners with educational and network opportunities. An alumnus of the University of Illinois, Samuel brings a varied research background to MATTER’s program team. Most recently, he worked at Rush University Medical Center tracking the cross-sectional and longitudinal expansion of Klebsiella pneumonaie carbapenemase (KPC) in clinical settings, and at Opternative improving user experience and prototyping new technologies for their online refractive eye exam. He also served at Bethesda Medical Centre in Kampala, Uganda as a medical missions volunteer coordinating medical outreach to rural villages.

Karuna Relwani

Program Associate Karuna helps develop meaningful programs for our members and partners. She graduated from the University of Pittsburgh with a bioengineering degree and a certificate in engineering for humanity. She has spent most of her time at the intersection of healthcare and technology, working both on the engineering and educational sides. In college, Karuna started an organization that hosted skills workshops in medical device design focused on innovations for UPMC physicians, and then she worked as a research engineer for Northwestern’s Global Health Initiative in TB diagnostics for limited resource settings.

Liz Kennedy

Program Coordinator As programming coordinator at MATTER, Liz helps implement meaningful programs that enrich the experience of our partner and member companies. She brings experience in program development and the non-profit sector, as well as a passion for healthcare and patient outcomes. A Pacific Northwest native, Liz holds a degree in pre-medical biology with a minor in anthropology from Eastern Washington University (EWU). Following graduation, Liz coordinated the K-12 mentorship and outreach programming for the Office of Community Engagement at EWU as an AmeriCorps member. In this role, she developed a College Access curriculum aimed at equipping school-aged students at risk of drop-out with the knowledge and tools to navigate post-secondary education.

James Taylor

Operations Coordinator James, a biology major from the University of Chicago, is driven by the concept of bringing scientific discovery out of the lab and into the hands of the rest of the world. As operations coordinator he is able to use his organizational and workplace management skills to embolden and empower MATTER’s community of entrepreneurs in the ways they need to find success. While in college, James was a competitive member of the UChicago varsity swim team, earning multiple Division III All-American honors, and draws from this experience his capacity for dedication and tenacity.

Caitlin Kryl

Events Assistant Caitlin assists the marketing team with logistics and execution for the many events that take place at MATTER. Previously, she spent two years on the development team at Carthage College, managing fundraising, networking, and digital engagement programs for students and alumni. Caitlin has a passion for social impact and has worked with a variety of organizations to develop their digital presences. Most recently, she collaborated with an ethical fashion company based in Northeast India. Caitlin has a bachelor of communications and digital media from Carthage College.

Noelle Sales-Griffin

Operations Assistant Noelle is a Chicago native who graduated from Kalamazoo College in 2012 with a major in biology and a minor in art. During her junior year, she studied and lived abroad in Ecuador for 6 months. While in college she held a leadership role on the Student Activities Committee and was a senior resident assistant. After college, she learned HTML/CSS and UX Design at The Starter League, later becoming Start League's office manager. Before joining The Starter League team, she worked at The University of Chicago Survey Lab administering surveys via phone in English and Spanish.

Patrick Flavin

Advisor Patrick Flavin is an entrepreneur with 20 years of experience in the life sciences field. Pat currently serves as the director of industry strategy at ContextMedia:Health, the leader in patient education at the point of care. He is also an advisor to MATTER, the Chicago healthcare technology startup center and innovation hub, where he previously served as executive director of partnerships. Prior to this role, Pat helped build several life sciences companies in the Chicago area, including MediChem Life Sciences and Advanced Life Sciences, both of which he helped take public on NASDAQ while serving as each company’s chief legal executive. As an attorney, Pat has served as counsel and advisor to several area companies in the medical device, diagnostic, health IT, and drug development space. In addition to his experiences as a chief legal executive, Pat also co-founded a venture capital fund to invest in and manage early-stage life science companies in the Midwest. Before working in the industry, he served as an assistant counsel to the Speaker of the Illinois House of Representatives.

Maryam Saleh, PhD

Advisor Maryam is passionate about moving research into the market, where it can have impact and improve lives. Her path started off at Cyberkinetics Neurotechnology Systems, Inc. where she teamed up with neuroscientists at Brown University to spin out a brain implant designed to help restore movement in paralyzed individuals. She’s also performed research herself, while pursuing her PhD in computational neuroscience at the University of Chicago. Most recently, she founded the Center for Device Development at Northwestern University, a fellowship program in medical device innovation, where doctors and engineers test drive their own medical device business ideas. Through her work, she’s come to realize the importance of building bridges between stakeholders in order to move opportunities forward. Her goal as MATTER’s vice president of programs is to actively engage with MATTER’s members to build an experience that is customized to address their individual needs.

David Johnson

Author-in-Residence Johnson is the CEO and founder of 4sight Health (4sighthealth.com), a boutique advisory firm specializing in healthcare thought capital, strategic advisory services, and venture investing. He is the author of Market vs. Medicine: America’s Epic Fight for Better, Affordable Healthcare, author-in-residence at the Health Management Academy, and writer of the widely read Market Corner commentaries. Johnson is also an advisor, investor, and board member of a number of early-stage healthcare companies. During his 28-year investment-banking career, he managed over $30 billion in healthcare revenue bonds and led significant strategic advisory engagements for health system clients.

Board of Directors

Our board of directors includes senior leaders from across the healthcare industry who are dedicated to fostering collaboration and innovation to spark meaningful change.


Jeffrey S. Aronin

Co-Chairman of the MATTER Board, Chairman & CEO, Marathon Pharmaceuticals Jeffrey S. Aronin has founded or led companies focused on addressing the unmet medical needs and improving the lives of patients with new advances and innovations in science and technology, particularly in the area of rare diseases.

Jeff is an entrepreneur, scientific innovator, and investor whose efforts have contributed to the development and approval of nearly a dozen new medicines and technologies and thousands of jobs in the Chicago area and throughout the country. Since 2011, he has served as chairman and chief executive officer of Paragon Health Equity, LLC a life science private equity and innovation fund. He has also led or served as Chairman of several Paragon Health Equities’ portfolio companies including Marathon Pharmaceuticals, LLC, Castle Creek Pharmaceuticals and Harmony Biosciences.

From 2009 to 2010, Jeff was chairman and chief executive officer of Lundbeck Inc., the U.S. subsidiary of a global pharmaceutical company that acquired Ovation Pharmaceuticals, Inc., a company he founded. Prior to founding Ovation Pharmaceuticals, he served in various leadership positions at American Health and Carter Wallace Laboratories.

He serves on the corporate boards of Discover Financial Services and Castle Creek Pharmaceuticals. He also serves as a director of the Economic Club of Chicago. Jeff is the founder and co-chairman of MATTER - a biotech incubator, a member of the Commercial Club, a Crown Fellow at the Aspen Institute, and a director on the executive committee of World Business Chicago among others. Jeff is active in the community and philanthropic endeavors including sitting on the boards of the Museum of Science and Industry, University of Chicago Medical Center and others. He lectures at the University of Chicago Booth School of Business and Northwestern University Kellogg School of Business.

Timothy P. Walbert

Co-Chairman of the MATTER Board, Chairman, President & CEO, Horizon Pharma Mr. Walbert joined Horizon Pharma in June 2008 as the president and chief executive officer and has served as chairman of the board of directors since 2010. Prior to joining Horizon Pharma, Mr. Walbert served as president, chief executive officer and director of IDM Pharma, Inc., a public biopharmaceutical company which was acquired by Takeda America Holdings, Inc., or Takeda, in June 2009.

Prior to IDM, Mr. Walbert served as executive vice president, commercial operations at NeoPharm, Inc., a public biopharmaceutical company. From 2001 to 2005, Mr. Walbert served as divisional vice president and general manager, immunology, where he led the global development and launch of the multi-indication biologic HUMIRA and divisional vice president, global cardiovascular strategy at Abbott, now AbbVie.

From 1998 to 2001, Mr. Walbert served as director, CELEBREX North America and arthritis team leader, Asia Pacific, Latin America, and Canada at G.D. Searle & Company. From 1991 to 1998, Mr. Walbert also held sales and marketing roles with increasing responsibility at G.D. Searle, Merck & Co., Inc. and Wyeth.

Mr. Walbert received his B.A. in business from Muhlenberg College, in Allentown, Pennsylvania. Mr. Walbert serves as chairman of the board of Egalet Corporation (NASDAQ: EGLT), chairman of the Illinois Biotechnology Innovation Organization (iBIO) and serves on the boards of the Biotechnology Innovation Organization (BIO), World Business Chicago (WBC) and the Greater Chicago Arthritis Foundation. 

Laura Ferris Anderson

Chief of Staff, Office of the Midwest Chairman, JPMorgan Chase & Co. Laura Ferris Anderson serves as chief of staff to the Office of the Midwest Chairman for JPMorgan Chase & Co. She manages the strategic planning and initiative implementation for the region’s senior leadership across multiple business lines and staff functions.

She had served as a senior banker in J.P. Morgan’s private banking business, managing relationships and banking needs for a wide variety of clients, including corporate executives and business owners. Previously, Laura served as a director of payments strategy, eCommerce, and of a major image enabled transformation of check processing. She also has experience in consulting and government affairs.

An active civic leader, Anderson serves on the executive committees of the board of directors of the Chicagoland Entrepreneurial Center and of the Wood Family Foundation. She serves on the board of directors of the IL Mentoring Partnership and the advisory board of Best Buddies Illinois as well as the Women’s boards of the Field Museum and the Joffrey Ballet.

She is a member of the Alumni Board of Governors of Georgetown University, where she earned a Bachelor of Science, a Master of Public Policy and a Master of Business Administration.

A native of Massachusetts, Anderson lives in Chicago with her husband, Matt, and their daughter, Ellen.

Andrew Cittadine

President & CEO, Diagnostic Photonics Andrew Cittadine is the president & chief executive officer of Diagnostic Photonics, which is developing advanced imaging technology to assist physicians in the real-time evaluation of tissue microstructure.

Andrew has 15 years of leadership experience as a co-founder or chief executive in four medical device companies. He co-founded and served as CEO of medical device startup American BioOptics, served as the interim CEO for venture-backed startup SonarMed, and co-founded Sensant Corporation, a Silicon Valley-based 3-D medical imaging firm that was acquired by Siemens.

Andrew received a BA in history and a BS and MS in electrical engineering from Stanford University where he was elected to Tau Beta Pi. He holds an MBA with distinction from the Kellogg School of Management at Northwestern University.

Steven Collens

CEO, MATTER Steven Collens is CEO of MATTER, the healthcare technology incubator and innovation center. MATTER opened in February 2015 and nurtures entrepreneurs and innovators building next-generation health IT, medical device, diagnostic and biopharma technologies. MATTER works with 200 healthcare technology ventures and the company partners with 10 hospitals and health systems, five universities and more than 50 industry-leading companies. Steven is also senior advisor at Pritzker Group Venture Capital.

Prior to assuming his current role, Steven was senior vice president at Pritzker Group, the investment firm led by Tony and J.B. Pritzker. In that capacity, he led the team that created 1871, Chicago’s center for digital startups that now houses more than 400 early-stage companies. He previously worked at Abbott in a variety of domestic and international functions, including product management, policy and public affairs. In 2005, Steven helped found ConstantWellness.com to give patients control over their health data and allow healthcare providers to coordinate care of their patients. Prior to Abbott, Steven served as legislative assistant to U.S. Senator Carol Moseley-Braun.

Steven holds an MBA from Northwestern University’s Kellogg School of Management and a BA from Washington University in St. Louis. He serves on the boards of 1871, the Ann & Robert H. Lurie Children’s Hospital of Chicago, the Chicago High School for the Arts and Hubbard Street Dance Chicago. He is also a Leadership Greater Chicago fellow and a member of the Economic Club of Chicago and the Commercial Club of Chicago.

Will Collie

General Manager of Healthcare Chicago, Edelman Will Collie is general manager of Edelman’s Chicago healthcare business where he now leads the company’s second largest team of healthcare communications specialists. Will is an integrated communications specialist who consults to major healthcare organizations on their marketing and communications strategy including digital media and advocacy engagement as well as issues and crisis.

Prior to his role in Chicago, Will led the company’s Australian healthcare operation delivering communications and engagement programs for pharmaceutical, patient, and consumer wellness organizations.

In 2014, Will was named the Australian Public Relations and Advertising industry Public Relations Professional of the Year across all sectors. That same year, his work in hearing health saw his team awarded the Golden Sabre best digital marketing program at The Holmes Report’s 2014 Asia-Pacific SABRE Awards.

In 2013, Will led Edelman in partnership with Sanofi Diabetes to win the Australian Public Relations Industry Association (PRIA) Golden Target Best Healthcare campaign, the Gold Award for Healthcare Providers/Medical Technology at The Holmes Report’s 2013 Asia-Pacific SABRE Awards as well as Australian pharmaceutical PRIME Awards Best Product Launch. He served on the National Communications Council Healthcare Committee from 2012 to 2015 and from 2010 to 2013 was a member of the Medicines Australia Media Working Group.

He has Bachelor of Arts degree from the Royal Melbourne Institute of Technology and has completed further communications and health policy studies at Sydney University and Lee Kuan Yew School of Public Policy in Singapore.

Thomas J. DeRosa

CEO, Welltower Tom DeRosa is chief executive officer of Welltower Inc. (NYSE: HCN), an S&P 500 company. Under his leadership, Welltower™ has grown into the global leader in health care real estate with a broad, diversified portfolio across the United States, United Kingdom and Canada. Together with its operating partners, the company is connecting health care delivery providers and properties to create more healthful environments for an aging population and to drive efficiencies in health care delivery. Since Mr. DeRosa assumed his current position in April 2014, Welltower’s enterprise value has grown to over $40 billion. He has served as a director of the company since 2004.

Mr. DeRosa is former vice chairman and chief financial officer of The Rouse Company, a position he held from September 2002 until November 2004 when The Rouse Company merged with General Growth Properties, Inc. From 1992 to September 2002, Mr. DeRosa held various positions at Deutsche Bank AG, DB Alex Brown, and Alex. Brown & Sons including global cohead of the Health Care Investment Banking Group. Mr. DeRosa’s extensive background in health care, real estate and capital markets has allowed him to uniquely position Welltower as a leading proponent for collaboration across the continuum of health care, including seniors housing, independent living, memory care, post-acute and outpatient medical facilities. Throughout his career, Mr. DeRosa has championed diversity and inclusiveness believing that innovation and business success stem from a creative mix of personalities, skills and backgrounds. Mr. DeRosa has extensive corporate governance experience and has sat on the Board of four NYSE companies: Dover Corporation; CBL & Associates Properties, Inc.; Empire State Realty Trust, Inc. and Health Care REIT, Inc. He has previously served on the Board of Directors of Georgetown University and as a member of the Health Advisory Board of the Michael Bloomberg School of Public Health at Johns Hopkins University. Mr. DeRosa currently is governor of the World Economic Forum and serves on the Board of Argentum, the largest senior living association in the US. He is a frequent speaker on the growth of aging populations and the devastating impact of dementia on people, their families and health care delivery systems.

Steven A. Gould, MD

Founder & Principal, The Gould Consulting Group For the past 2 years, Steven A. Gould led Chicago Innovation Mentors (CIM), which supports university-based and local new technology innovation ventures through the use of mentor teams. MATTER acquired CIM in January 2016. Steve has extensive and broad-based experience in both clinical and scientific research in an academic environment, and executive management throughout the entire life cycle of an entrepreneurial biotechnology company.

Steve is also the founder and principal of The Gould Consulting Group LLC, which provides advisory services to companies and universities seeking to develop and capitalize on biotechnology and life science innovations, and to venture investors evaluating promising and potentially transforming companies working in areas of disruptive science. Steve was previously a scientific founder and chairman and CEO of Northfield Laboratories Inc., a publicly traded biotechnology company that was focused on developing a hemoglobin-based oxygen carrier as a blood substitute. Prior to Northfield he was chief of surgery at Michael Reese Hospital and Medical Center and professor of surgery at the University of Chicago and then the University of Illinois at Chicago.

He has dealt with the full spectrum of issues related to financing start-up companies from the initial venture investment through multiple subsequent rounds, the initial public offering and follow-on offerings, and the wide range of challenges in the development of new and innovative therapies. Steve received his BA from Williams College and his MD from Boston University School of Medicine. He completed his residency training in surgery at Yale and the University of Vermont, and a research fellowship at Michael Reese and the University of Chicago.

James L. Madara, MD

CEO & Executive Vice President, American Medical Association James L. Madara, MD, serves as the CEO and executive vice president of the American Medical Association, the nation’s largest physician organization. He holds the academic title of adjunct professor of pathology at Northwestern University.

Prior to joining the AMA, Dr. Madara served as CEO of the University of Chicago Medical Center, bringing together the university’s biomedical research, teaching, and clinical activities.

Immediately prior to arriving at the AMA, Dr. Madara served as senior advisor with Leavitt Partners, a highly innovative healthcare consulting firm started by former Secretary of Health and Human Services, Mike Leavitt. Dr. Madara has served as dean of the Pritzker School of Medicine and dean of the Biological Sciences Division at the University of Chicago, as the chair of pathology and laboratory medicine at the Emory University School of Medicine and as director of the Harvard Digestive Diseases Center.

In addition to Modern Healthcare often naming him to its list of the nation’s 50 most influential physician executives, as well as to its list of the nation’s 100 most influential people in healthcare, he is a past recipient of a prestigious MERIT Award from the National Institute of Health. Dr. Madara earned his medical degree from Hahnemann Medical College in Philadelphia, completed his internship and residency at New England Deaconess Hospital, his fellowship at Brigham and Women’s Hospital, and his post-doctoral research training in cell biology at Harvard Medical School, where he joined the faculty and became a tenured professor.

Peter McNerney

Founder & Senior Advisor, Thomas, McNerney & Partners Pete McNerney has over 40 years of health care operating and venture capital experience. In addition to co-founding Thomas, McNerney & Partners, Pete co-founded Coral Ventures, and has served on the board of numerous early and mid stage health care companies. Prior to joining Coral, Pete co-founded The Kensington Group, a firm providing services to venture backed companies and founded and was CEO of Memtec North America. Previously, Pete spent 11 years with Baxter Healthcare Corporation, where he held various general management positions in the U.S., Europe, Middle East and Southeast Asia. He has served as president of the Minnesota Venture Capital Association and as a trustee of Blue Cross and Blue Shield of Minnesota. Pete received a B.A. from Yale and an M.B.A. from Stanford University and holds a CPA.  Pete was a 2014 fellow at Harvard's Advanced Leadership Initiative program and is currently an adjunct lecturer at Kellogg School of Management, Northwestern University.

James O’Connor, Jr.

Global Head of Venture Capital, William Blair James O’Connor is the global head of Venture Capital for William Blair and Company. Mr. O’Connor focuses on extending the company’s advisory services among venture capital firms, corporate venture groups, and entrepreneurial hubs in domestic and international markets.

Mr. O’Connor is a senior investment professional with over 20 years of private equity and venture capital experience. Prior to joining William Blair, Mr. O’Connor was a senior managing director at MVC Capital, a boutique middle market private equity firm focused on equity and debt offerings. Mr. O’Connor also held senior management positions within Motorola, Inc. Before Motorola, he worked for A.T. Kearney as a management consultant and the U.S. Treasury Department in the areas of domestic and international finance as a White House Fellow. Additionally, he held roles at Ariel Capital Management, Sidley & Austin, the U.S. House Ways & Means Committee and the City of Chicago Finance Committee.

Mr. O’Connor is founding chairman of 1871 and the Chicago Entrepreneurial Center (CEC) and a board member of MATTER, the Chicagoland Chamber of Commerce, the Big Shoulders Fund for the Archdiocese of Chicago’s inner-city school fund and serves as a trustee and vice-chair of the board of the Field Museum of National History. He is a former board member of the Chicago Urban League, Kohl Children’s Museum, and Children’s Home + Aid. He is a Henry Crown Leadership Fellow of the Aspen Institute, a White House Fellow, a Leadership Greater Chicago Fellow, and a member of the Council on Foreign Relations Young Leadership Program. He holds a BA (Government) and JD from Georgetown University and an MBA from Northwestern University's Kellogg School of Management.

David Ormesher

Founder & CEO, closerlook inc. David Ormesher provides leadership and direction for closerlook, inc., a digital marketing agency serving the pharmaceutical industry. As founder and CEO, Ormesher has grown it into a recognized leader in creating innovative relationship-marketing solutions that help pharmaceutical brands build and maintain meaningful relationships with their most valuable healthcare professionals.

Since founding the company in 1987, David has created a rich, cohesive culture at closerlook by maintaining a hands-on approach to building client success and sustaining lasting account relationships. He has guided the growth and evolution of the firm, attracting a world-class team of account, strategy, user experience, design, technology, data analytics and relationship-marketing services experts. David is a frequent speaker at marketing conferences and a recognized thought leader in the areas of interactive and relationship marketing for the pharmaceutical industry.

This past year, Ormesher was named to the board of the Lurie Children’s Hospital Foundation and to the Innovation Board of the XPRIZE Foundation. He serves on the boards of the Lyric Opera of Chicago; i.c.stars, an innovative business and leadership training program for inner city youth; and is a founder of Bigger Future, a social-enterprise building the capacity of high-potential entrepreneurs in Rwanda. He is also an adjunct professor at the Illinois Institute of Technology Stuart School of Business where he teaches customer relationship management.

James (Jim) Robinson

President of Americas, Astellas Jim Robinson is president, Americas Operations, for Astellas Pharma, a global research-based pharmaceutical company committed to serving unmet medical needs in oncology, immunology, infectious diseases, urology, neuroscience, and kidney diseases. Jim leads the company’s pharmaceutical operationsin North and South America and is a member of Astellas’ management committee.

Jim has nearly 25 years of experience in the pharmaceutical industry. Before assuming his present role, Jim led the company’s pharmaceutical commercial organization in the US , a role that he held since 2013.Jim joined Astellas in 2005 as the vice president of health systems responsible for managed markets, reimbursement strategy, state government affairs & government accounts.

Jim started his pharma career at Schering-Plough in 1992 as a sales representative and moved through positions of increasing responsibility until he was promoted to vice president of hepatitis sales and managed care in 2003. In this position he led the largest specialty pharmaceutical sales division within Schering-Plough.

Jim serves on several boards, including the Pharmaceutical Research and Manufacturers of America (PhRMA) Board of Directors.He is a native of Illinois and is a graduate of DePaul University in Chicago.

Sheli Z. Rosenberg

Principal, Roselin Investments Sheli Z. Rosenberg is a principal with Roselin Investments. Prior to January 1, 2014, she was a member of the Skadden, Arps, Slate, Meagher & Flom LLP Real Estate Group, having joined the firm’s Chicago office in 2011. Sheli is the former president, chief executive officer and vice chairman of Equity Group Investments, L.L.C. She joined EGI in 1980 as the company’s general counsel and rose to become CEO before retiring in 2003. Prior to joining EGI, Sheli was one of six managing partners at Schiff Hardin & Waite, Chicago, specializing in real estate, finance, and corporate law, and was the first woman to become a capital partner at that firm.

Ms. Rosenberg serves on the board of directors/trustees of a number of public and private corporations, foundations, and community and charitable organizations.

She is a forceful advocate for women in business and is past president of The Chicago Network and director of The National Partnership for Women & Families and The Women’s Issues Network Foundation. Sheli is a co-founder and former president of the Center for Executive Women at Kellogg Graduate School of Management. She earned a BA in History and Government from Tufts University, and a JD from Northwestern School of Law.

Ellen A. Rudnick

Clinical Professor of Entrepreneurship, Chicago Booth & Executive Director, Polsky Center for Entrepreneurship & Innovation Prior to joining the Chicago Booth faculty, Ellen Rudnick spent 25 years in business management and entrepreneurial activities, primarily in the healthcare and health information services industries. During this time, she was president and CEO of Healthcare Knowledge Resources, president of HCIA, chairman of Pacific Biometrics, and corporate vice president of Baxter Healthcare Corporation.

She serves on numerous corporate and non-profit boards including Liberty Mutual, First Midwest Bank, HMS Holdings, Patterson Companies, NorthShore University HealthSystem Research Institute and Foundation and the CEC/1871. She previously served on the Oxford Health Plans board prior to its sale to United Healthcare. She is an advisor to many start-ups that emerge from ChicagoBooth’s entrepreneurship programs.

Rudnick has been the recipient of a number of honors, including Today’s Chicago Woman 20th Anniversary Hall of Fame, the YWCA Leadership Award, and the IVCA’s Richard J. Daley award.  Rudnick holds a BA from Vassar College and an MBA from Chicago Booth.

David Schonthal

Professor of Entrepreneurship & Innovation, Kellogg School of Management David Schonthal is a clinical assistant professor of entrepreneurship & Innovation at Northwestern University’s Kellogg School of Management where he teaches courses in new venture creation and leads the school’s internal startup accelerator – the Zell Scholars program. He also serves as a business designer at the global innovation and design consultancy, IDEO, where he focuses on venture design and corporate entrepreneurship.

David is also a co-founder of Fusion Ventures, an investment and advisory firm focused on growing technology startups in the early stages of their development. He was formerly director of strategy and venture development at Tavistock Life Sciences, a private investment firm located in San Diego, CA, and has held numerous senior management positions at startups in the technology and life sciences sectors. David began his career as a management consultant for Andersen, Deloitte and PricewaterhouseCoopers based in both the United States and the United Kingdom.

David serves as a member of Chicago Mayor Rahm Emanuel’s technology, innovation, and entrepreneurship council, ChicagoNEXT, and was previously an advisor to the State of Illinois’s Invest Illinois venture capital fund. He currently mentors and advises with several startup accelerators and incubators throughout the United States, including Techstars, CONNECT, San Diego Sports Innovators (SDSI), and Chicago Innovation Mentors.

David earned his MBA from the Kellogg School of Management at Northwestern University and his BA in international relations from Boston University.

Ramona Sequeira

President, United States Business Unit, Takeda Ramona Sequeira is president of Takeda Pharmaceuticals U.S.A., Inc. She leads the U.S. Business Unit for Takeda, and serves as a member of Takeda Pharmaceutical’s executive team. Ms. Sequeira joined Takeda in 2015.

Through her work with Takeda and prior to that Eli Lilly, Ms. Sequeira has over 25 years experience in the pharmaceutical industry. She has led businesses in Canada, Europe and the U.S. Through leadership roles in multiple markets, across cultures and within different healthcare systems she has successfully launched products, transformed businesses, and delivered sustainable growth. Since joining Takeda, Ms. Sequeira has shifted the structure of Takeda’s U.S. Business Unit and altered the investment mix to enable focus, agility and sustainable growth. Known for her forward-looking approach, Ms. Sequeira leads her organization to gain and utilize customer insights to effectively tailor business strategies and build trust with stakeholders.

Ms. Sequeira enjoys participating in leadership forums inside and outside of Takeda to share her views on the role of trust and reputation in long-term company success. A passionate advocate of talent development, diversity and inclusion, she is an active mentor and coach to numerous individuals both inside and outside Takeda. Ms. Sequeira has a keen interest in authentic leadership and has led numerous executive development programs.

Ms. Sequeira is committed to industry’s role in shaping a positive environment that rewards pharmaceutical innovation and ensures patients have access to innovative medicines that can help them have better health. She is a member of the PhRMA Board of Directors, and a previous board member of the Association of British Pharmaceutical Industry. She is also a member of the Board of Directors for Matter, a Chicago-based healthcare technology incubator. In addition, Ms. Sequeira is a member of the Board of Trustees for Lake Forest Academy, a college preparatory boarding and day school for grades 9 through 12 located in Lake Forest, Illinois.

Ms. Sequeira received a B.Sc. with honors in molecular genetics and molecular biology from the University of Toronto, and later received an MBA from McMaster University in Hamilton, Ontario. She lives with her husband of over 20 years and their two teenage children near Takeda’s headquarters in Deerfield, Illinois.

Rishi Shah

Founder & CEO, Outcome Health Rishi Shah, chief executive officer and founder of Outcome Health (formerly ContextMedia), is a successful media and technology entrepreneur who founded ContextMedia in 2006 to improve health outcomes by serving actionable health information to chronic disease patients. Today, the company’s digital place-based media networks and mobile media offerings impact hundreds of millions of patient visits across 10,000+ hospital & health systems and the firm’s clients include 33 of the 35 largest life science manufacturers.

Rishi serves on the board of directors of many civic organizations including Young Presidents Organization (YPO), 1871, MATTER, and the Academy for Global Citizenship, an internationally renowned charter school. In 2012, he co-founded a personal venture investment firm, Jumpstart Ventures, through which he has made over 45 investments in fast growing early- to late-stage startups.

Previous to Outcome Health, and while in his first year in college, Rishi founded the Northwestern Business Review, a Northwestern University-based collaborative publication distributed to more than 60 leading campuses worldwide. In high school, he founded a home computer consulting firm whose clients were acquired by a national electronics retailer. Rishi has also started and led several non-profit initiatives including the Urban-Suburban Domestic Exchange Initiative, a program sponsored by the Gates Foundation to facilitate cross-school interaction.

Crain’s Chicago Business recognized Rishi as the youngest ever member of their annual 40-Under-40 class in 2009 and he frequently lectures at Northwestern University’s Kellogg School of Management & McCormick School of Engineering. A Chicago, IL resident, Rishi is an avid fan of his hometown Bulls, ancient Indian philosophy, and smoothies.

Jim Sullivan

Vice President, Discovery, AbbVie James Sullivan, Ph.D., is vice president, discovery. In this role, he is responsible for AbbVie’s research efforts in a variety of diseases including cancer, Alzheimer’s disease, hepatitis C, and a number of autoimmune disorders. He oversees a global network of scientists that includes AbbVie researchers at sites in the United States and Europe, and external research partners around the world. Dr. Sullivan is a member of the R&D Leadership Team that has responsibility for the advancement of compounds in all stages of development, the Executive Licensing Steering Committee and the Scientific Governing Board for Abbvie. He is also an executive sponsor for the AbbVie Women in Science organization. Jim joined Abbott in 1991 and has held various positions in the R&D organization.  

Jim has advanced more than 100 compounds into clinical development across a number of disease states and technology platforms. These include AbbVie’s recently launched combination product for HCV, the-first-in- class Bcl2 selective inhibitor, Venclexta and multiple compounds currently in Phase II or III trials. He has authored/co-authored more than 130 scientific publications and is an inventor on 11 patents. Jim is an adjunct faculty member at Northwestern University and serves on the board of a number of companies and foundations including Calimmune, Alector, Regis Technologies, Accelerator, BIO, MATTER, and C2ST. He earned his bachelor's degree and Ph.D. in biochemistry from Trinity College in Dublin, Ireland, and conducted post-doctoral research in neurobiology at Northwestern University.

Nancy Sullivan

CEO & Managing Director, IllinoisVENTURES Nancy Sullivan serves as the CEO and managing director of IllinoisVENTURES, LLC. With over 15 years of experience in the commercialization and entrepreneurial sector, Nancy leads the IllinoisVENTURES, LLC investment portfolio. Ms. Sullivan oversees $70 million+ in assets under management. She is responsible for overall fund operations including serving as the main point of contact for limited partner base and the investment management of leading portfolio companies.  

Nancy promotes the development of new companies commercializing complex technologies by assisting the companies in obtaining venture capital funding, recruiting management talent and obtaining necessary business services. She serves on the boards of two Chicago based startups, Personify and Diagnostic Photonics.  

Nancy earned her MBA from Northwestern University's Kellogg School of Management and a Master's in Biotechnology, from Northwestern. She earned her Bachelor's degree in Business Administration from Loyola University.

Advisory Boards

Our advisory board members are leaders from among our industry, health system and academic partners. They help us design our programs and initiatives.

Industry Advisory Board

  • Kevin Tyler

    Vice President of Investments, Welltower
  • Jeffrey Blackman

    Vice President of Portfolio Management, American Medical Association
  • Bob Chib

    Executive Director, Corporate Strategy, Planning, and Initiative Management and Delivery, Astellas
  • Holly Copeland

    Director of Public Affairs & Corporate Social Responsibility, Horizon Pharma
  • Jerry DeVault

    Global Client Service Partner & Life Sciences Leader, Americas Central Region, EY
  • Daniel Gandor

    Head of Digital Accelerator, USA, Takeda
  • Nathan Hansen

    Managing Director of the Midwest Life Sciences Practice, Accenture
  • Addison McGuffin

    Vice President of IT Strategy & Innovation, Health Care Service Corporation
  • Evan Norton

    Divisional Vice President of Venture Investments, Abbott Ventures
  • Francisco Rausa, PhD

    Senior Principal Research Scientist, Future Therapeutics & Technology, AbbVie
  • Matthew Warrens

    Vice President of Innovation Partnerships, OSF HealthCare

Health Systems Advisory Board

  • Gabrielle Cummings Hatley

    Senior Vice President, NorthShore University HealthSystem
  • Michael Dandorph

    Executive Vice President, Rush University Medical Center
  • Dan Derman, MD

    Chief Innovation Officer, Northwestern Medicine
  • Monica Heenan

    Chief Ambulatory Executive, Lurie Children's Hospital
  • Jason Keeler

    Executive Vice President & Chief Operating Officer, University of Chicago Medicine
  • Karl Kochendorfer, MD

    Assistant Vice Chancellor & Chief Health Information Officer, University of Illinois Hospital & Health Sciences System
  • David Lundal

    System Vice President & Chief Information Officer, Presence Health
  • Tanvir Mangat

    Chief Strategy Officer, Sinai Health System
  • Jeffrey Tillery, MD

    Chief Transformation Officer, OSF HealthCare

Chicago Innovation Mentors Advisory Board

  • Steven A. Gould, MD

    Chair, CIM Advisory Board
  • Steven C. Kuemmerle, Ph.D.

    Director, Technology Commercialization and Licensing, Polsky Center for Entrepreneurship and Innovation, University of Chicago
  • Jeff Coney

    Director of Economic Development, Northwestern University
  • Suseelan Pookote

    Assistant Director of Business Development at the Office of Technology management, University of Illinois
  • Warren Ribley

    President & CEO, Illinois Biotechnology Organization (iBIO) & the iBIO Institute
  • Greg Morin

    Director of Strategy & Innovation, Argonne National Lab

Mentors-in-Residence

Our mentors-in-residence are successful, experienced entrepreneurs who have built healthcare businesses from the ground up. They advise our members on every facet of building new ventures, coaching members through unexpected obstacles and setting them up for success.


Jordan Dolin

Co-founder, Emmi Solutions Jordan is a 25+ year veteran of Chicago’s entrepreneurial community. He has founded two companies, helped to launch a third and has served as advisor/investor/board member for several dozen early stage companies across multiple industries. He is a frequent speaker, has published numerous articles on the topic of entrepreneurialism and is an adjunct professor at the University of Chicago’s Booth School of Business.

For the past 14 years, Jordan has been with Emmi Solutions, a company he founded in 2002. Emmi is a healthcare technology company that leverages interactive media to engage and empower patients to take a more active role in their care. The company combines innovation and expertise to help leading healthcare organizations improve clinical and financial outcomes. In late 2012, Primus Capital, a private equity firm based in Cleveland Ohio, acquired Emmi Solutions.

Jordan combines an entrepreneur’s mentality with well over a decade’s worth of experience in the healthcare industry. Prior to founding Emmi, Jordan spent 3 years on the leadership team of an artificial intelligence software company and 14 years successfully leading a consumer products company that he co-founded in 1986. Jordan received a bachelor's degree from the University of Wisconsin Madison and a master's degree from Northwestern University in Evanston, IL.

Steve Gould, MD

Founder & Principal, The Gould Consulting Group For the past 2 years, Steven A. Gould led Chicago Innovation Mentors (CIM), which supports university-based and local new technology innovation ventures through the use of mentor teams. MATTER acquired CIM in January 2016. Steve has extensive and broad-based experience in both clinical and scientific research in an academic environment, and executive management throughout the entire life cycle of an entrepreneurial biotechnology company.

Steve is also the founder and principal of The Gould Consulting Group LLC, which provides advisory services to companies and universities seeking to develop and capitalize on biotechnology and life science innovations, and to venture investors evaluating promising and potentially transforming companies working in areas of disruptive science. Steve was previously a scientific founder and chairman and CEO of Northfield Laboratories Inc., a publicly traded biotechnology company that was focused on developing a hemoglobin-based oxygen carrier as a blood substitute. Prior to Northfield he was chief of surgery at Michael Reese Hospital and Medical Center and professor of surgery at the University of Chicago and then the University of Illinois at Chicago.

He has dealt with the full spectrum of issues related to financing start-up companies from the initial venture investment through multiple subsequent rounds, the initial public offering and follow-on offerings, and the wide range of challenges in the development of new and innovative therapies. Steve received his BA from Williams College and his MD from Boston University School of Medicine. He completed his residency training in surgery at Yale and the University of Vermont, and a research fellowship at Michael Reese and the University of Chicago.